VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,091,000 | -19.5% | 46,929 | -44.9% | 0.47% | -6.7% |
| Q1 2018 | $1,356,000 | +513.6% | 85,200 | +326.0% | 0.51% | +614.1% |
| Q1 2017 | $221,000 | -59.8% | 20,000 | -10.7% | 0.07% | -65.2% |
| Q3 2016 | $550,000 | -31.9% | 22,400 | -44.1% | 0.20% | -24.4% |
| Q2 2016 | $808,000 | +127.6% | 40,100 | +197.0% | 0.27% | +134.8% |
| Q1 2016 | $355,000 | -55.2% | 13,500 | +73.1% | 0.12% | -56.6% |
| Q4 2015 | $793,000 | -61.3% | 7,800 | -32.2% | 0.26% | -61.3% |
| Q3 2015 | $2,051,000 | -54.1% | 11,500 | -42.8% | 0.68% | -48.0% |
| Q2 2015 | $4,465,000 | +2.2% | 20,100 | -8.6% | 1.32% | -8.7% |
| Q1 2015 | $4,370,000 | +59.0% | 22,000 | +14.6% | 1.44% | +34.0% |
| Q4 2014 | $2,748,000 | – | 19,200 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |